Post by Sobi - Swedish Orphan Biovitrum AB (publ)

Delighted to share that we are welcoming Åsa Riisberg and Mikael Dolsten as new members of the Board of directors at Sobi.   Their combined experience and expertise will further strengthen the Board’s ability to guide our long-term strategy and support sustainable growth.   Åsa Riisberg and Mikael Dolsten were elected at the Annual General Meeting on 6 May 2026.     #Sobi #RareDiseases #BoardOfDirectors #InvestorRelations